Clinical Trials for Miltenyi Biotec

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Miltenyi Biotec

Clinical Trials (9)

NCT07153289
CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)
PHASE1/PHASE2Not yet recruiting
38 participants
Started: Jul 31, 2026 · Completed: Dec 31, 2028
2 conditions7 sponsors0 locations
NCT07192900
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
PHASE1Not yet recruiting
10 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2037
4 conditions4 sponsors1 location
NCT07087847
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
NANot yet recruiting
18 participants
Started: Sep 1, 2025 · Completed: Sep 30, 2028
5 conditions2 sponsors1 location
NCT05705570
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
PHASE1Recruiting
30 participants
Started: Feb 7, 2023 · Completed: Dec 1, 2028
6 conditions2 sponsors1 location
NCT05281809
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
PHASE2Recruiting
30 participants
Started: Apr 19, 2022 · Completed: Dec 1, 2037
9 conditions4 sponsors1 location
NCT04464434
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
PHASE4Recruiting
50 participants
Started: Sep 17, 2020 · Completed: Oct 1, 2030
8 conditions4 sponsors12 locations
NCT04832607
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
PHASE3Recruiting
149 participants
Started: Aug 27, 2019 · Completed: Sep 30, 2028
4 conditions10 sponsors33 locations
NCT02600208
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
PHASE2/PHASE3Active, not recruiting
60 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT00959140
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from Matched Related Donors
NAActive, not recruiting
20 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2025
1 condition2 sponsors1 location